Literature DB >> 22038366

A meta-analysis of the biomarkers associated with coronary artery lesions secondary to Kawasaki disease in Chinese children.

Jingjing Chen1, Yali Liu2, Wenhua Liu3, Zubo Wu1.   

Abstract

The biomarkers associated with coronary artery lesions (CAL) secondary to Kawasaki disease (KD) in Chinese children were investigated by using Meta-analysis. We searched documents published from January 1997 to December 2009 from medical electronic databases. According to inclusion and exclusion criteria, eligible full-text papers were identified. We conducted a comprehensive quantitative analysis by using Stata10.0 statistical software package to assess the heterogeneity among the documents, calculated the summary effect and analyze publication bias and sensitivity. A total of 92 documents and 16 biomarkers were identified. All documents were case-control studies, and included 2398 patients in CAL group and 5932 patients in non-CAL (NCAL) group. The Meta-analysis showed that the levels of platelet count, platelet hematocrit (PCT), neutrophils count, platelet distribution width (PDW), mean platelet volume (MPV), erythrocyte sedimentation rate (ESR), cardiac troponin I (cTnI), and endothelin-1 (ET-1) in CAL group were significantly higher than those in NCAL group, and serum albumin (Alb) and hemoglobin (Hb) levels were significantly lower in CAL group (all P<0.05). White blood cell (WBC) count, serum sodium, matrix metalloproteinase 9 (MMP-9), total cholesterol (TC), hematocrit (HCT) and CD3+T lymphocytes percentage had no statistically significant difference between the two groups. In conclusion, our results indicated that the 10 biomarkers including platelet count, neutrophils count, PCT, PDW, MPV, ESR, cTnI, ET-1, Alb and Hb were associated with CAL, and may be involved in the pathogenesis of CAL. The biomarkers of WBC count, serum sodium, MMP-9, TC, HCT, and CD3+T lymphocytes percentage bore no relationship with the development of CAL among Chinese children with KD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038366     DOI: 10.1007/s11596-011-0587-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  24 in total

1.  Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function.

Authors:  M Iemura; M Ishii; T Sugimura; T Akagi; H Kato
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

2.  S100A8, S100A9 and the S100A8/A9 heterodimer complex specifically bind to human endothelial cells: identification and characterization of ligands for the myeloid-related proteins S100A9 and S100A8/A9 on human dermal microvascular endothelial cell line-1 cells.

Authors:  Ines Eue; Simone König; Jolanthe Pior; Clemens Sorg
Journal:  Int Immunol       Date:  2002-03       Impact factor: 4.823

Review 3.  Role of ET-1 in the regulation of coronary circulation.

Authors:  Michel Lavallée; Eric Thorin
Journal:  Can J Physiol Pharmacol       Date:  2003-06       Impact factor: 2.273

Review 4.  Platelets in inflammation and atherogenesis.

Authors:  Meinrad Gawaz; Harald Langer; Andreas E May
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

5.  A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group.

Authors:  A S Beiser; M Takahashi; A L Baker; R P Sundel; J W Newburger
Journal:  Am J Cardiol       Date:  1998-05-01       Impact factor: 2.778

6.  Guidelines for reading case-control studies.

Authors:  M J Lichtenstein; C D Mulrow; P C Elwood
Journal:  J Chronic Dis       Date:  1987

7.  Platelet size in health and hematologic disease.

Authors:  J D Bessman; L J Williams; P R Gilmer
Journal:  Am J Clin Pathol       Date:  1982-08       Impact factor: 2.493

Review 8.  Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis?

Authors:  Ryuji Fukazawa; Shunichi Ogawa
Journal:  J Nippon Med Sch       Date:  2009-06       Impact factor: 0.920

Review 9.  Kawasaki syndrome.

Authors:  Jane C Burns; Mary P Glodé
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

Review 10.  [Clinical utility of ulinastatin, urinary protease inhibitor in acute Kawasaki disease].

Authors:  Tsutomu Saji
Journal:  Nihon Rinsho       Date:  2008-02
View more
  12 in total

Review 1.  Biomarkers in vasculitis.

Authors:  Paul A Monach
Journal:  Curr Opin Rheumatol       Date:  2014-01       Impact factor: 5.006

2.  Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.

Authors:  Lorna Stemberger Maric; Ivica Knezovic; Neven Papic; Branko Mise; Srdan Roglic; Leo Markovinovic; Goran Tesovic
Journal:  Rheumatol Int       Date:  2014-11-28       Impact factor: 2.631

3.  Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalities.

Authors:  Goshgar Mammadov; Hui Hui Liu; Wei Xia Chen; Guo Zhen Fan; Rui Xue Li; Fei Fei Liu; Sama Samadli; Jing Jing Wang; Yang Fang Wu; Huang Huang Luo; Dong Dong Zhang; Wei Wei; Peng Hu
Journal:  Clin Exp Med       Date:  2019-11-16       Impact factor: 3.984

4.  A new scoring system for coronary artery abnormalities in Kawasaki disease.

Authors:  Hui Hui Liu; Wei Xia Chen; Man Man Niu; Qi Jiang; Zhen Qiu; Guo Zhen Fan; Rui Xue Li; Goshgar Mammadov; Yang Fang Wu; Huang Huang Luo; Dong Dong Zhang; Peng Hu
Journal:  Pediatr Res       Date:  2021-09-28       Impact factor: 3.953

5.  Plasma MASP-1 concentration and its relationship to recovery from coronary artery lesion in children with Kawasaki disease.

Authors:  Rui-Xia Song; Qing-Mei Zou; Xiao-Hui Li; Nan-Ping Xu; Ting Zhang; Jin Fu; Xiao-Dai Cui
Journal:  Pediatr Res       Date:  2015-11-04       Impact factor: 3.756

6.  Differentially expressed genes, lncRNAs, and competing endogenous RNAs in Kawasaki disease.

Authors:  Changsheng Guo; Yuanqing Hua; Zuanhao Qian
Journal:  PeerJ       Date:  2021-05-12       Impact factor: 2.984

7.  Acute Kawasaki disease with emphasis on the echocardiographic profile: A single center experience.

Authors:  Hala S Hamza; Wessam A Raouf; Asmaa Z Zaher; Hala M Agha
Journal:  Glob Cardiol Sci Pract       Date:  2017-10-31

8.  Neutropenia Is Not Associated With the Outcomes in Patients With Kawasaki Disease.

Authors:  Yunjia Tang; Miao Gang; Weiguo Qian; Jin Ma; Qiuqin Xu; Haitao Lv
Journal:  Front Pediatr       Date:  2021-06-04       Impact factor: 3.418

9.  Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.

Authors:  Yan-Li Chen; Juan-Li Wang; Wei-Qin Li
Journal:  Eur J Pediatr       Date:  2014-06-03       Impact factor: 3.183

Review 10.  Can Coronary Artery Involvement in Kawasaki Disease be Predicted?

Authors:  Sunil J Ghelani; Neha S Kwatra; Christopher F Spurney
Journal:  Diagnostics (Basel)       Date:  2013-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.